Eduardo Fonseca is the founder of EndoQuest Robotics. Latest round: Series D. Backed by Crescent Enterprises, Dr. Fred Moll. Based in Houston, United States.
Eduardo Fonseca is the CEO of EndoQuest Robotics, a Houston-based surgical robotics company focused on developing flexible endoluminal surgical technology for scar-free procedures. He is leading the company through its PARADIGM clinical trial, which has FDA Investigational Device Exemption approval for human trials. EndoQuest Robotics recently closed a Series D-2 funding round to advance its ELS System towards U.S. market authorization.
Full founder directory · Investor directory · Company funding database · Fundraising library